# Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers

> **NCT02603770** · PHASE1 · COMPLETED · sponsor: **Luye Pharma Group Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Lipid Metabolism Disorder

## Interventions

- **DRUG:** XueZhiKang
- **DRUG:** Lovastatin

## Key facts

- **NCT ID:** NCT02603770
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603770, "Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02603770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*